Avegen
Avegen builds the HealthMachine™ digital patient support platform, sold via B2B SaaS subscriptions to pharmaceutical companies, hospitals, and research institutions for deploying modular, white-label patient engagement programmes across chronic and rare disease therapy areas.
- Company typePrivate
- Founded2015
- HeadquartersLondon, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Avegen does
Avegen Limited is a UK-based digital health company founded in 2015 and headquartered in London, with a secondary office in India. The company develops the HealthMachine™ platform — a web and mobile application suite that enables pharmaceutical companies, hospitals, clinicians, and research institutions to build and deploy modular, white-label digital patient support programmes across multiple therapy areas including chronic diseases (diabetes, cardiovascular, respiratory) and rare diseases. Core platform capabilities include a modular pathway builder for personalised patient journeys, symptom and treatment tracking tools, educational resources, an analytics dashboard for adherence and engagement KPIs, and brand-matched white-label deployment.
The platform is built on AWS cloud infrastructure within the European Union, with security features including encryption at rest, TLS 1.2, two-factor authentication, and pseudonymisation. Avegen sells to enterprise pharma life science teams through a direct field sales motion, complemented by demo-driven demand generation on its website. The business model is B2B SaaS subscription/recurring licensing for the HealthMachine™ platform, with pricing handled via quote-based enterprise sales rather than public list pricing. Avegen reports 30+ clients, 20 solutions launched globally, 2.7 million downloads across all digital solutions, 2 million+ patients in its data asset, and a 90% repeat partner rate. The company appears to be founder-led, privately held, and bootstrapped or minimally funded based on the absence of disclosed funding rounds.
Avegen firmographics
Firmographics- Name
- Avegen
- Legal name
- Avegen Limited
- Website
- https://avegenhealth.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Avegen builds the HealthMachine™ digital patient support platform, sold via B2B SaaS subscriptions to pharmaceutical companies, hospitals, and research institutions for deploying modular, white-label patient engagement programmes across chronic and rare disease therapy areas.
- Ownership category
- akta.pro rank
Avegen industry classification
Industry- Product category
- Digital Patient Engagement Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ)
- akta.pro secondary industries
- Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ), Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)
Keywords
Where Avegen is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Avegen business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Platform Licensing/Subscription: B2B SaaS model providing pharmaceutical companies access to the HealthMachine™ platform for digital patient support programs. The platform supports multiple therapy areas with modular tools for patient engagement, tracking, and analytics.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Avegen product offering
Product offeringCore offering
Avegen builds and licenses the HealthMachine™ platform — a white-label, modular digital patient support system delivered via web and mobile apps for pharmaceutical and life science companies. The platform enables configurable patient pathways (symptom tracking, education, medication management, check-ins, care team connection), analytics on adherence and engagement, and branded multi-market deployment with compliance built in.
Product overview
Avegen offers a unified digital health platform called HealthMachine™ (consisting of web and mobile applications) designed to connect every step of the patient and prescriber experience. The platform provides modular tools including Analytics Dashboard for tracking KPIs (adherence, adoption, engagement), Digital Patient Support Programs with symptom tracking, education, and care team connections, Tracking Tools for surveys and monitoring, and Brand-Matched Experience for white-label customization. The platform is built for pharma and life science companies to deliver consistent, human, and impactful patient support programs across multiple therapy areas and markets.
Differentiator
Problem solved
Functional benefit
Brands
- HealthMachine™: Digital health management platform consisting of a web application and mobile application for healthcare support programs, enabling patient monitoring, health tracking, and data analytics for pharmaceutical companies and healthcare organizations.
Products and services
- HealthMachine™ Platform HealthMachine™ is Avegen's flagship digital health platform comprising a web application and mobile application that enables pharmaceutical companies, hospitals, clinicians, and research organisations to deliver digital patient support programmes. It supports patient health record management, appointment scheduling, reporting, patient monitoring, medication management, symptom tracking, educational resources, check-ins, and care team connections across multiple therapy areas and markets. The platform is white-label capable, allowing partners to deploy branded patient experiences with built-in compliance and analytics.
Quantifiable outcome
- 2.7 million downloads across all digital solutions
- +2 more outcomes
Companies that use Avegen
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Avegen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Avegen partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights6 records
Avegen competitors and assessment
Company assessmentBroad incumbents
- IQVIA: IQVIA is the largest life sciences-focused technology and services provider, offering patient engagement, RWE, and commercial solutions to pharma. It competes with Avegen in digital patient support programs at the high end of the market and represents the dominant incumbent Avegen must displace or partner with.
- Veeva Systems: Veeva provides the de facto CRM and commercial platform for most large pharma companies, with an expanding suite of patient and HCP engagement products. Its installed base in pharma makes it a direct competitive threat to Avegen's enterprise sales motion.
Direct peers
- OptimizeRx: OptimizeRx is a digital health platform that delivers patient and provider engagement solutions to pharma at the point of prescribing. Like Avegen, it focuses on improving medication adherence and therapy initiation, making it a close comparable in target buyer and use case.
- AssistRx: AssistRx provides specialty therapy initiation and patient support program technology to pharma and specialty pharmacies. Its iAssist platform directly overlaps with Avegen's white-label patient support program offering in chronic and specialty therapy areas.
- TrialCard: TrialCard (now part of Bounteous) operates a patient access, affordability, and engagement platform for pharma manufacturers. Its hub services and digital adherence programs are directly comparable to Avegen's patient support and adherence modules.
- Medisafe: Medisafe is a medication adherence platform combining a patient-facing app with pharma-sponsored programs. It targets the same chronic disease adherence and engagement use cases as Avegen, with a similar white-label model for pharma deployment.
- Atlantis Healthcare: Atlantis Healthcare provides patient adherence and behavior-change programs for pharma, with both nurse-led and digital channels. Its therapy-area focus and combination of digital and human support closely mirror Avegen's positioning.
Emerging players
- S3 Connected Health: S3 Connected Health builds digital therapeutics and patient support platforms for pharma and medtech, with deep experience in chronic disease and combination products. It is a relevant comparable as a smaller, focused player in the same space as Avegen.
- Hale Health (by Resmed): Hale Health provides patient engagement and remote care platforms for clinical teams and life sciences, including chronic condition management. Its modular, white-label approach to digital patient support parallels Avegen's HealthMachine platform.
- Dosed: Dosed builds branded, white-label patient support and adherence apps for pharma, with a focus on chronic and specialty therapy. Its GTM and product model directly overlap with Avegen's pharma-focused white-label platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Avegen social profiles
Digital presenceAvegen financial estimates
Financial estimateRevenue estimate
Valuation estimate
Avegen leadership team
Management profileNumber of profiles
Profiles13 records
Avegen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Avegen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Avegen
What does Avegen do?
Avegen builds and licenses the HealthMachine™ platform — a white-label, modular digital patient support system delivered via web and mobile apps for pharmaceutical and life science companies. The platform enables configurable patient pathways (symptom tracking, education, medication management, check-ins, care team connection), analytics on adherence and engagement, and branded multi-market deployment with compliance built in.
Is Avegen a public or private company?
Avegen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Avegen founded?
Avegen was founded in 2015. It employs 51 to 100 people.
Where is Avegen based?
Avegen is headquartered in London, United Kingdom, in the Europe region.
How does Avegen make money?
One revenue line is on record: platform Licensing/Subscription.
Who are Avegen's main competitors?
Broad incumbents on record are IQVIA and Veeva Systems. Direct peers are OptimizeRx, AssistRx, TrialCard, Medisafe and Atlantis Healthcare. Emerging players are S3 Connected Health, Hale Health (by Resmed) and Dosed.
Does Avegen have an API?
No public API is recorded for Avegen.
What industry is Avegen in?
Avegen's product category is Digital Patient Engagement Software. Its primary akta.pro industry code is HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up), with a secondary code of HLALABAJ, Patient Engagement, Education & Messaging Platforms (portal/CRM integrated). Its NAICS code is 5132 and its SIC code is 7372.